Patent · US Active

Triazoles as Kv3 inhibitors

US11180461B2 · kind B2 · utility

0Cited by

10References

5Claims

0Family size

Assignee

Autifony Therapeutics Limited · GB

Inventors

Agostino Marasco · Verona, IT
Giuseppe Alvaro · Stevenage, GB
Anne DECOR · Verona, IT
Dieter Hamprecht · Verona, IT
Paolo Dambruoso · Verona, IT
Simona Tommasi · Verona, IT

Key dates

Filing date	Feb 7, 2020
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Feb 7, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of formula (I) are of use in the modulation of Kv3.1, Kv.3.2 and Kv3.3 channels and have utility in the treatment or prevention of related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.